Abstract
In summary, a combination of high-dose antibody therapy as a preconditioning agent and low-dose tacrolimus as a maintenance therapy appears to allow slow tapering of immunosuppression to remarkably low levels.
| Original language | English (US) |
|---|---|
| Pages (from-to) | S18-S19 |
| Journal | Transplantation Reviews |
| Volume | 17 |
| Issue number | 4 SUPPL. |
| DOIs | |
| State | Published - Oct 2003 |
All Science Journal Classification (ASJC) codes
- Transplantation
Fingerprint
Dive into the research topics of 'Combined bone marrow and solid organ transplantation with alemtuzumab induction'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver